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Edited by Michael R. BubbAbstract DLC-1 (deleted in liver cancer 1) is a Rho GTPase-
activating protein that is able to inhibit cell growth and suppress
tumorigenesis. We have used homologous recombination to inac-
tivate the mouse DLC-1 gene (Arhgap7). Mice heterozygous for
the targeted allele were phenotypically normal, but homozygous
mutant embryos did not survive beyond 10.5 days post coitum.
Histological analysis revealed that DLC-1/ embryos had de-
fects in the neural tube, brain, heart, and placenta. Cultured
ﬁbroblasts from DLC-1-deﬁcient embryos displayed alterations
in the organization of actin ﬁlaments and focal adhesions.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Embryonic lethal1. Introduction
The Rho GTPase-activating proteins (GAPs) are negative
regulators of the Rho family of small GTPases, which control
cellular processes such as proliferation, cytoskeleton assembly,
and gene expression [1,2]. The RhoGAP activity resides in a
conserved sequence domain of 150 amino acids that en-
hances the hydrolysis of bound GTP to convert Rho proteins
to their inactive state [3,4].
The rat p122 RhoGAP molecule and its human orthologue,
DLC-1 (deleted in liver cancer 1), are 120 kDa polypeptides
that contain a RhoGAP domain [5,6] and two other potential
functional domains, a sterile alpha motif (SAM) protein inter-
action domain and a lipid-binding StAR-related lipid-transfer
(START) domain [7,8]. In vitro studies indicated that p122/
DLC-1 can act as a GAP for RhoA and Cdc42 [5,9], and
p122 also stimulated the hydrolysis of phosphatidylinositolAbbreviations: DLC-1, deleted in liver cancer 1; dpc, days post coitum;
ES, embryonic stem cell; GAP, GTPase-activating protein; SAM,
sterile alpha motif; START, StAR-related lipid-transfer
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suppressor activity and has been shown to inﬂuence the mor-
phology, adhesion, proliferation, and tumorigenicity of cul-
tured cells [9–12]. To provide an animal model for
investigating the biological functions of DLC-1, we have gen-
erated mice with a targeted disruption of the DLC-1 gene and
found that loss of DLC-1 activity leads to embryonic lethality
by midgestation.2. Materials and methods
2.1. Localization of the DLC-1 transcript in mouse embryos
In situ hybridization of 35S-labeled sense or antisense riboprobes to
sections of wild type 10 days post coitum (dpc) mouse embryos was
performed by Molecular Histology, Inc. (Gaithersburg, MD), using
previously described methods [13]. The riboprobes were transcribed
from mouse DLC-1 cDNA inserts in pBluescript (Stratagene).2.2. Construction of a mouse DLC-1 gene targeting vector
The mouse DLC-1 genomic clone kG2 [14,15] was used as template
to generate two DNA segments by PCR for insertion into the pPNT
vector [16]. A 1.3-kb 5 0 arm containing exon 4 was ampliﬁed using
the primers 5 0-ggaattccgagaagctcatattgtatg and 5 0-cggatccgactgtcatt-
taaccagccc and ligated into the EcoRI/BamHI sites of the vector. A
5.8-kb 3 0 arm extending from intron 5 to part of exon 9 was ampliﬁed
with the primers 5 0-taatgtcgacctcccgatgtgcgtagacactatcc and 5 0-
taatgcggccgcggagtcatctggttttctttcacagc and cloned into the NotI/XhoI
sites of the plasmid. The NotI-cut targeting vector was electroporated
into the HM-1 embryonic stem (ES) cell line [17], and the cells were
cultured in G418 and ganciclovir as described [18]. Southern blots of
XbaI-cut genomic DNA from drug-resistant ES cell colonies were
hybridized to a 32P-labeled external probe in intron 3, which will detect
XbaI bands of 3.5 kb in the wild type gene and 2.2 kb in the correctly
targeted allele, due to the introduction of an XbaI site in pPNT. Four
ES clones harboring the disrupted gene were identiﬁed and all yielded
chimeric mice when injected into C57BL/6 blastocysts. The agouti
progeny of chimeras mated with C57BL/6 mice were genotyped by
Southern blot hybridization of tail biopsy DNA and also by PCR
using two primer pairs: (1) a primer in the neomycin-resistance cassette
of pPNT (5 0-gcagcctctgttccacatacactt) and a primer from intron 4 (5 0-
gcaacacttggtcagacttctg), which amplify an 130 bp product speciﬁc for
the targeted allele; (2) primers from exon 5 (5 0-acccattcagtcagtccacc
and 5 0-attgcgtctcttcagctcc), which amplify a 260-bp band from the wild
type gene. The disrupted allele was maintained in the heterozygous
state on a mixed C57BL/6 · 129/Ola background.2.3. Northern blot analysis of DLC-1 mRNA
Total RNA was prepared from mouse tissues using the TRIzol re-
agent (Invitrogen) and analyzed by Northern blot hybridization as pre-
viously described [15]. The blot was probed with a 32P-labeled 1.3-kbblished by Elsevier B.V. All rights reserved.
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re-hybridized to a 376-bp mouse L19 ribosomal protein cDNA frag-
ment as a control for loading.
2.4. Histological analysis of mutant embryos
Embryos from matings of DLC-1+/ mice were dissected from the
uterine horns on 12.5, 10.5, and 9.5 dpc, and the yolk sacs were re-
served for DNA preparation and genotyping. Placentae and 9.5 dpc
embryos were ﬁxed in 10% neutral buﬀered formalin, and 12.5 and
10.5 dpc embryos were placed in Bouins ﬁxative. Sections were stained
with hematoxylin/eosin (H&E) for microscopic examination.
2.5. Mouse embryo ﬁbroblast cultures
Embryos from intercross matings were removed on 9.5 dpc, and the
cells were dissociated by trypsinization and cultured in Dulbeccos
modiﬁed Eagles medium supplemented with 10% FBS and antibiotics.
Cells were genotyped by PCR, and studies were performed on wild
type and DLC-1/ cells prior to passage 10. Subconﬂuent cultures
plated on glass coverslips were incubated for 12 h in medium contain-
ing 0.5% fetal bovine serum prior to ﬁxation with 10% neutral buﬀered
formalin. Staining of actin ﬁbers with Texas Red-X phalloidin was
performed according the manufacturers protocol (Molecular Probes,
Eugene, OR). Focal adhesions were visualized by indirect immunoﬂu-
orescence using anti-vinculin monoclonal antibody (V9131, Sigma)
and FITC-conjugated anti-mouse IgG (Sigma F9887), both diluted
1/100. Vinculin-stained cells were grown on coverslips coated with
10 lg/ml ﬁbronectin. The preparations were examined on a Zeiss Axi-
ophot epiﬂuorescent microscope equipped with the appropriate ﬁlters,
and selected areas were recorded as 16-bit grayscale images on a
Photometrics CoolSNAP monochrome camera controlled by an Apple
Macintosh computer. Digital images were analyzed and pseudocolored
by IPLab 3.6.2 software (Scanalytics, Inc., Fairfax, VA).3. Results
3.1. Localization of the DLC-1 transcript in mouse embryos
DLC-1 mRNA is widely expressed in adult mouse tissues
[15] and was detected in 9.5 dpc embryos by RT-PCR (not
shown). In situ hybridization showed that the DLC-1 tran-
script was present in a number of tissues in 10 dpc embryos,Fig. 1. Localization of the DLC-1 transcript in mouse embryos on 10 dpc b
sagittal section through embryo: ba, branchial arch; fb, forebrain; hb, hindb
(C) and dark-ﬁeld (D) images of placenta. De, decidua; GC, giant cells; Sp,although the levels were relatively low in the neuroepithelium
of the brain and neural tube (Fig. 1A and B). In the placenta,
DLC-1 mRNA was enriched in the trophoblast cells of the
spongiotrophoblast and labyrinth compared to the maternal
decidua (Fig. 1C and D).
3.2. Targeted disruption of the mouse DLC-1 gene
The mouse DLC-1 gene (Arhgap7) consists of 14 exons span-
ning 50 kb on mouse chromosome 8 [14,15]. To inactivate the
gene by homologous recombination, a targeting vector was de-
signed to delete exon 5 (Fig. 2), which encodes a serine-rich do-
main of the protein. Loss of the 1427-bp exon 5 will cause a
reading frame shift that will result in premature translation ter-
mination and synthesis of a truncated polypeptide containing
the ﬁrst 77 amino acids of the DLC-1 protein, which comprises
the SAM domain, plus 23 novel residues due to the altered
reading frame. Two independent ES cell lines generated mice
capable of germline transmission of the targeted DLC-1 allele.
When DLC-1+/ mice were crossed, no homozygous mutant
oﬀspring were obtained, indicating that DLC-1/ embryos
died in utero. Embryos of all three genotypes were observed
at 10.5 dpc (Fig. 2D).
3.3. Characterization of mice heterozygous for the targeted
DLC-1 gene
Adult DLC-1+/ mice did not display any gross physical or
behavioral abnormalities, and histopathological analysis of tis-
sues from seven-month old mice (performed by the Pathology
Phenotyping Service of the Veterinary Resources Program, Of-
ﬁce of Research Services, National Institutes of Health,
Bethesda, MD) did not reveal any lesions speciﬁc for the het-
erozygous animals. On Northern blots, there was a reduction
in the level of the wild type 6.5-kb DLC-1 mRNA in tissues
of DLC-1+/ animals but no sign of an 5.1-kb transcript ex-
pected from the mutated allele (Fig. 3). The DLC-1 transcript
lacking exon 5 may be targeted for degradation by the non-y in situ hybridization. Bright-ﬁeld (A) and dark-ﬁeld (B) images of a
rain; he, heart; hp, hepatic primordia; n, neuroepithelium. Bright-ﬁeld
spongiotrophoblast; La, labyrinth.
Fig. 2. Targeted mutation of the mouse DLC-1 gene. (A) Diagram of the structural organization of the 1084-amino acid mouse DLC-1 polypeptide
[15], showing the SAM, serine-rich, RhoGAP, and START domains. (B) Schematic representation of the central region of the wild type Arhgap7
locus, the targeting vector, and the targeted allele. Exons are indicated by numbered boxes, and XbaI sites (X) in the genomic DNA and the pPNT
vector are shown. Gray boxes denote the herpes simplex virus thymidine kinase (TK) and the bacterial neomycin-resistance (neo) cassettes of pPNT.
A solid box indicates the location of the probe used for Southern blot hybridization. (C) A Southern blot of XbaI-cut genomic DNA from drug-
resistant ES cell colonies, showing hybridization of the probe to the 2.2 kb band characteristic of the disrupted gene in one clone. (D) Southern blot
of XbaI-digested yolk sac DNA from 10.5 dpc embryos obtained from an intercross mating. Hybridization to the upstream probe indicated the
presence of wild type (+/+), heterozygous (+/), and homozygous (/) mutant littermates. On the right, the same blot was stripped and reprobed
with a 32P-labeled fragment from exon 5, to conﬁrm the deletion of this exon in the DLC-1/ embryo.
Fig. 3. Comparison of DLC-1 mRNA in wild type and heterozygous
mutant mice. Northern blot of liver and heart total RNA (20 lg per
lane), isolated from matched wild type (+/+) and heterozygous (+/)
siblings from two litters, 15 and 11. The same blot was hybridized
sequentially to a DLC-1 cDNA probe and a mouse ribosomal protein
L19 cDNA probe (RpL19).
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cies with premature translation termination codons [19] and
may not yield signiﬁcant amounts of a truncated protein.
3.4. Abnormalities in DLC-1/ embryos
Histological analysis of embryos from intercross matings
showed that DLC-1/ embryos were absent or necrotic on
12.5 dpc (not shown). At 10.5 and 9.5 dpc homozygotes dis-
played defects in several organ systems, which varied in sever-
ity. One embryo at 9.5 dpc lacked the forebrain and had
incomplete morphogenesis of the hindbrain, branchial arches,
and heart (Fig. 4B and E). In a second DLC-1/ embryo from
the same litter, organogenesis had progressed further but was
aberrant; the anterior neural tube was open and contorted,
the hindbrain had a narrow lumen with a hyperplastic neuro-
epithelium, and the branchial arches and the chambers of the
heart were distorted (Fig. 4C and F). Placental development
was also aﬀected by DLC-1 deﬁciency (Fig. 5). The wild type
placental labyrinth at 10.5 dpc contains sinusoids with mater-
nal enucleated red blood cells and embryonic blood vessels
with nucleated fetal erythrocytes. In DLC-1/ placentae, for-
mation of the embryonic vasculature was reduced, and clusters
Fig. 4. Abnormal development of DLC-1/ embryos. Serial transverse H&E stained sections of three 9.5 dpc embryos from the same litter; embryo
1 is wild type (+/+), and embryos 5 and 6 were homozygous for the targeted DLC-1 allele (/). (A) Section of embryo 1 at level of branchial arches
(ba). The forebrain (fb), hindbrain (hb), and otic pits (ot) are indicated. (B) Section of embryo 6 at a similar level, showing lack of forebrain and
incomplete development of branchial arches. (C) Section of embryo 5 at level of branchial arches; note open neural tube (nt) in the forebrain and
disorganization of the branchial arches, the hind brain neuroepithelium, and the otic pit. (D) Section through heart of embryo 1. AC, common atrial
chamber; BC, bulbus cordis; VC, ventricular chamber. (E) Section through heart of embryo 6, showing incomplete formation of the chambers.
(F) Section through heart of embryo 5, in which the architecture of the chambers is distorted.
Fig. 5. Placental defects in DLC-1/ embryos. (A) H&E stained section of placental labyrinth of wild type 10.5 dpc embryo sinuses with maternal
red blood cells are adjacent to embryonic blood vessels containing nucleated fetal erythrocytes. (B) Placenta of DLC-1/ littermate embryo has
reduced vascularization of the labyrinth. Defective embryonic blood vessels contain immature fetal erythrocytes (asterisks).
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served in the trophoblast layer.
3.5. Cytoskeleton alterations in DLC-1/ mouse embryo
ﬁbroblasts
Fibroblasts isolated from 9.5 dpc DLC-1/ embryos were
viable and able to proliferate in culture, but the organization
of cytoskeletal proteins diﬀered from that of cells from wild
type embryos (Fig. 6). The DLC-1-deﬁcient cells had fewer
long actin stress ﬁbers and a reduced number of focal adhe-sion-like structures when stained with antibodies against vin-
culin, an actin-binding protein present in focal adhesions [20].4. Discussion
Spontaneous and targeted mutations of genes encoding pro-
teins involved in Rho GTPase signaling pathways produce a
range of phenotypes, including neurological disorders in hu-
mans [2,3]. In this communication, we report that DLC-1, a
Fig. 6. Altered cytoskeletal organization in DLC-1-deﬁcient mouse embryo ﬁbroblasts. Cells from wild type (A, C) and DLC-1/ (B, D) littermate
embryos were stained with ﬂuorescent phalloidin (A, B) and anti-vinculin antibodies (C, D).
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ing cellular functions during early murine development. The
DLC-1-deﬁcient embryos were found to have neural tube de-
fects, but these are a common occurrence in mouse gene
knockouts that result in death at early to midgestation and
may be secondary to failure of other organ systems [21].
Lethality at this stage is often due to placental or cardiac de-
fects [22,23]. Abnormalities in both tissues were found in
homozygous DLC-1 mutant embryos, at a developmental
stage when the DLC-1 transcript is normally expressed, and
the primary cause of embryonic death is not known.
Recently, p122/DLC-1 has been localized to focal adhesions
[24], sites at which extracellular matrix receptors are linked to
the actin cytoskeleton and which contain numerous regulatory
and structural proteins [20,25]. We have shown that the forma-
tion of actin stress ﬁbers and vinculin-rich focal adhesions was
reduced in DLC-1/ mouse embryo ﬁbroblasts. DLC-1 has
been implicated in the phosphoinositide and Rho GTPase sig-
naling pathways, both of which regulate stress ﬁber and focal
adhesion assembly [2,10,26], and loss of DLC-1 may interfere
with development by adversely aﬀecting cell adhesion and
migration.
Two human genes have been identiﬁed that encode proteins
closely related to DLC-1, KIAA0189/STARD8 [27] and
DLC2/STARD13 [28]. The mouse orthologues of the DLC-
1-like proteins are apparently unable to compensate during
embryogenesis for the lack of DLC-1, due to divergent func-
tions or diﬀerent expression patterns. The reduced DLC-1
mRNA levels in heterozygotes appear to be compatible with
normal development; however, DLC-1 haploinsuﬃciencymight produce phenotypic changes on a diﬀerent genetic back-
ground or after challenge with carcinogens or other agents.
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